TABLE 3.
Total | Enthesophytes | No Enthesophytes | P Value | |
---|---|---|---|---|
Complications, n (%) | 15 (21.7) | 8 (44.4) | 7 (13.7) | .027 |
Persistent pain/numbness | 8 | 4 | 4 | .196 |
Tendon calcification or thickening | 4 | 3 | 1 | .130 |
Triceps adhesion | 1 | 0 | 1 | .322 |
Olecranon cyst | 1 | 1 | 0 | .331 |
Dehiscence | 1 | 0 | 1 | .322 |
SANE score | 89.9 ± 14.6 | 80.3 ± 24.8 | 92.6 ± 8.8 | .103 |
VAS score | 0.9 ± 1.7 | 2.1 ± 2.9 | 0.6 ± 0.9 | .062 |
KJOC score | 84.5 ± 20.0 | 85.6 ± 17.5 | 84.2 ± 20.9 | .875 |
VR-12 score | 0.8 ± 0.1 | 0.8 ± 0.2 | 0.8 ± 0.1 | .590 |
MEPS score | 90.7 ± 29.7 | 84.4 ± 17.0 | 93.0 ± 11.4 | .217 |
QuickDASH score | 9.7 ± 16.3 | 16.1 ± 21.8 | 7.1 ± 12.7 | .202 |
aData are reported as mean ± SD, unless otherwise specified. Bolded P value indicates a statistically significant difference between patients with enthesophytes versus no enthesophytes (P < .05). KJOC, Kerlan-Jobe Orthopaedic Clinic; MEPS, Mayo Elbow Performance Score; QuickDASH, Quick Disabilities of the Arm, Shoulder and Hand; SANE, Single Assessment Numeric Evaluation; VAS, visual analog scale; VR-12, Veterans RAND 12-Item Health Survey.